Abstract
Today, especially with the use of magnetic resonance imaging (MRI) and revised diagnostic criteria for multiple sclerosis (MS), individuals with MS are receiving the diagnosis at younger ages and often during less severe stages of the clinical course. Thus, both men and women with MS must make many important life decisions and these often include decisions about reproduction. This chapter is limited to women with MS, but it is also noted that affected males also face many challenges in this area. The prototypic MS patient is a young woman of childbearing age. Here, the discussion will focus on reproductive decision-making including documented concerns of women contemplating a pregnancy and specific genetic/reproductive counseling. Pediatric MS will also be discussed as many girls with this relatively recent diagnosis are now approaching reproductive ages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5:932–6.
Trojano M, Lucchese G, Graziano G, et al. Geographical Variations in sex ratio trends over time in multiple sclerosis. PLoS One. 2012;7(10):e48078 doi: 10.1371.
Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278–86.
Ziemssen T, De Stefano N, Pia Sormani M, et al. Optimizing therapy early in multiple sclerosis: an evidence-based view. Mult Scler Relat Disord. 2015;4:460–9.
http://www.nationalmssociety.org/Treating-MS/Medications. 25 Nov 2015.
Alwan S, Yee IM, Dybalski M, et al. Reproductive decision-making after the diagnosis of multiple sclerosis (MS). Mult Scler. 2013;19:351–8.
Alwan S, Dybalski M, Yee IM, Greenwood T, et al. Multiple sclerosis and pregnancy: a comparison study. Can J Neurol Sci. 2012;40:590–6.
http://narcoms.org/. 20 Nov 2015.
Eichhorst H. Multiple Sklerose und Spastiche Spinalparalyse. Med Klin. 1913;9:1617–9.
Carton H, Vlietinck R, Debruyne J, et al. Risks of Multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry. 1997;62:29–333.
Herrera M, Ramagopalan SV, Orton S, et al. Parental transmission of MS in a population-based Canadian cohort. Neurology. 2007;69:1208–12.
Sadovnick AD, Dircks A, Ebers GC. Genetic counseling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet. 1999;56:118–22.
Willer CJ, Dyment DA, Risch NJ, et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100:12877–82.
Dyment DA, Yee IM, Ebers GC, Sadovnick AD. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry. 2006;77:258–9.
Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature. 1995;377:150–1.
Ebers GC, Sadovnick AD, Dyment DA, et al. Parent of origin effect in multiple sclerosis: observations in half siblings. Lancet. 2004;363:1773–4.
Willer CJ, Dyment DA, Cherny S, et al. A genome-wide scan in forty large pedigrees. J Hum Genet. 2007;52:955–62.
O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology. 2013;40:1–12.
Robertson NP, Fraser M, Deans J, et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 1996;119:449–55.
Westerlind H, Ramanujam R, Uvehag D, et al. Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain. 2014;137:770–8.
Oksenberg JR. Decoding multiple sclerosis: an update on genomics and future directions. Expert Rev Neurother. 2013;2013(12 Suppl):11–9.
Wang Z, Sadovnick AD, Traboulsee AL, et al. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron. 2016;90:948–54.
Skinner S, Guimond C, Butler R, et al. An assessment of genetic counseling services for individuals with multiple sclerosis. J Genet Couns. 2015;24:46–57.
Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84:478–85.
Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann. 2010;41:241–50.
Bove R, Alwan S, Friedman J, et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol. 2014;124:1157–68.
Romano AM. A changing landscape: implications of pregnant women’s internet use for childbirth educators. J Perinat Educ. 2007;16:18–24.
Lagan BM, Sinclair M, Kernohan WG. What is the impact of the Internet on decision-making in pregnancy? A global study. Birth. 2011;38:336–45.
Dwosh E, Guimond C, Sadovnick AD. Reproductive counselling in MS: a guide for healthcare professionals. Int MS J. 2003;10(2):67.
Dwosh E, Guimond C, Sadovnick AD. Reproductive counselling for MS: a rationale. Int MS J. 2003;10(2):52–9.
Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19:1261–7.
Banwell B, Kennedy J, Sadovnick D, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009;72:232–9.
Brenton JN, Banwell BL. The management of pediatric demyelinating disease: multiple sclerosis and acute disseminated encephalomyelitis. Neurotherapeutics. 2016;13:84–95.
Yeh EA. Current therapeutic options in pediatric multiple sclerosis. Curr Treat Options Neurol. 2011;3:544–59.
Alwan S, Chambers CD, Armenti VT, Sadovnick AD. The need for a disease-specific prospective pregnancy registry for multiple sclerosis. Mult Scler Relat Disord. 2015;4:6–17.
Rommer PS, Zettl UK, Kieseier B, et al. Requirement for safety monitoring for approved multiple sclerosis therapies: an overview. Clin Exp Immunol. 2014;175:397–407.
Houtchens MK, Kolb CM. Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol. 2013;260:1202–14.
Financial Disclosure
The author reports no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Wien
About this chapter
Cite this chapter
Sadovnick, A.D. (2017). Genetic Considerations and Reproductive Planning in Women with MS. In: Houtchens, M., Sadovnick, A. (eds) Health Issues in Women with Multiple Sclerosis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4858-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-4858-7_1
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-4856-3
Online ISBN: 978-3-7091-4858-7
eBook Packages: MedicineMedicine (R0)